How to Choose a Research Peptide Supplier: Nine Checks That Actually Predict Quality

The market is loud with quality claims. The checks below predict actual product quality; the marketing noise mostly doesn’t.

Nine signals, ranked by predictive power

1. Per-batch COA matched to the vial. Non-negotiable and the single strongest discriminator — the COA field guide covers reading it once you have it.

2. Purity honesty. A vendor reporting 97.8% on one peptide and 99.4% on another is telling the truth about something. Uniform top-end claims across 80 SKUs is arithmetic fiction.

3. CAS discipline. Cross-check every CAS against PubChem for your exact salt form. This is free and catches a shocking share of vendors.

4. Structural documentation. Mass spectra you can sanity-check with your own molar math (calculator) beat any purity percentage.

5. Cold-chain realism. Lyophilized ships stable at ambient for short transits; reconstituted never should. What a supplier packs tells you what they believe about their own product’s stability.

6. Storage guidance specificity. “-20 °C, dry, desiccated, away from light” is a protocol; “store in a cool place” is a shrug.

7. Catalog breadth-with-depth. Vendors carrying both BPC-157 and GHK-Cu at documented batch level are running real QC across sequences; single-hype-compound storefronts are arbitrage.

8. Complaint behavior. Ask a technical question before buying. A vendor who routes it to a human who knows HPLC gradients is a vendor who can answer when something’s wrong.

9. Regulatory posture. For compounds under the 503A cat-2 review — the PCAC-banned five — vendors asserting compliance should be able to say what they’re asserting in one accurate sentence. The July 2026 tracking page shows why that matters right now.

What these checks caught historically

The systematic audits worth knowing: Van Wagoner et al. in JAMA (2017) found the majority of online “SARM” products mislabeled against their own declared contents — every one of the nine checks above would have flagged most of those vendors. That study is the existence proof that buyer-side evaluation works.

What Vyroval commits to on each of these nine lines is stated on the quality process page.

For laboratory research use only. Not medical advice.